<DOC>
	<DOC>NCT02532673</DOC>
	<brief_summary>The purpose of this study is to determine whether HIV patients on Atazanavir who have Hyperbilirubinemia have different outcomes from those without Hyperbilirubinemia.</brief_summary>
	<brief_title>Impact of Hyperbilirubinemia Among HIV Patients Treated With Atazanavir</brief_title>
	<detailed_description />
	<mesh_term>Hyperbilirubinemia</mesh_term>
	<mesh_term>Atazanavir Sulfate</mesh_term>
	<criteria>Diagnosis of Human immunodeficiency virus Treatment with Atazanavir 18 yrs and older</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>